These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21554939)

  • 1. Use of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosis.
    Haeri A; Sadeghian S; Rabbani S; Anvari MS; Boroumand MA; Dadashzadeh S
    Int J Pharm; 2011 Jul; 414(1-2):16-27. PubMed ID: 21554939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes.
    Haeri A; Sadeghian S; Rabbani S; Anvari MS; Lavasanifar A; Amini M; Dadashzadeh S
    Int J Pharm; 2013 Oct; 455(1-2):320-30. PubMed ID: 23867987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated estradiol benzoate liposomes as a potential local vascular delivery system for treatment of restenosis.
    Haeri A; Sadeghian S; Rabbani S; Anvari MS; Erfan M; Dadashzadeh S
    J Microencapsul; 2012; 29(1):83-94. PubMed ID: 22047547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characteristics of liposomes are decisive for their antirestenosis efficacy following local delivery.
    Haeri A; Sadeghian S; Rabbani S; Shirani S; Anvari MS; Dadashzadeh S
    Nanomedicine (Lond); 2017 Jan; 12(2):131-145. PubMed ID: 27876438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomes.
    Haeri A; Sadeghian S; Rabbani S; Anvari MS; Ghassemi S; Radfar F; Dadashzadeh S
    Carbohydr Polym; 2017 Feb; 157():1461-1469. PubMed ID: 27987857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells.
    Valizadeh H; Ghanbarzadeh S; Zakeri-Milani P
    Drug Dev Ind Pharm; 2015; 41(9):1558-65. PubMed ID: 25311425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units.
    Jain B; Singh B; Katare OP; Vyas SP
    J Liposome Res; 2010 Jun; 20(2):105-14. PubMed ID: 19698000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
    Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
    Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy.
    Zucker D; Andriyanov AV; Steiner A; Raviv U; Barenholz Y
    J Control Release; 2012 Jun; 160(2):281-9. PubMed ID: 22019556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.
    Avnir Y; Ulmansky R; Wasserman V; Even-Chen S; Broyer M; Barenholz Y; Naparstek Y
    Arthritis Rheum; 2008 Jan; 58(1):119-29. PubMed ID: 18163482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate.
    Zhang H; Wang ZY; Gong W; Li ZP; Mei XG; Lv WL
    Int J Pharm; 2011 Jul; 414(1-2):56-62. PubMed ID: 21596128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of EP-liposomes and Span 40-niosomes.
    Ning M; Guo Y; Pan H; Zong S; Gu Z
    Pharmazie; 2006 Mar; 61(3):208-12. PubMed ID: 16599261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of an anti-cancer agent via steroid coupled liposomes.
    Mishra PK; Gulbake A; Jain A; Vyas SP; Jain SK
    Drug Deliv; 2009 Nov; 16(8):437-47. PubMed ID: 19839788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.
    Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O
    Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles.
    Zou W; Cao G; Xi Y; Zhang N
    Drug Deliv; 2009 Jan; 16(1):15-23. PubMed ID: 19555304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.